Citation Impact
Citing Papers
Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice
2009
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer
2012
Hallmarks of Cancer: The Next Generation
2011 Standout
Translocations of the RARα gene in acute promyelocytic leukemia
2001
Crucial Involvement of Tumor-Associated Neutrophils in the Regulation of Chronic Colitis-Associated Carcinogenesis in Mice
2012
A High-Resolution STS, EST, and Gene-Based Physical Map of the Hereditary Paraganglioma Region on Chromosome 11q23
1997
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Brown and beige fat: development, function and therapeutic potential
2013 Standout
Contribution of platelets to tumour metastasis
2011 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
2001
The biology and function of fibroblasts in cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
2011 Standout
The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
2013
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Nonresolving Inflammation
2010 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Acquisition of Oncogenic Potential by RAR Chimeras in Acute Promyelocytic Leukemia through Formation of Homodimers
2000
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Molecular genetics of acute promyelocytic leukemia
1999
Role of the histone deacetylase complex in acute promyelocytic leukaemia
1998 Nature
Histone deacetylases and cancer: causes and therapies
2001 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer
2016
Protective effects of matrix metalloproteinase-12 following corneal injury
2013
Astrocytic abnormalities and global DNA methylation patterns in depression and suicide
2014
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Leukaemogenesis: more than mutant genes
2009
What We Talk About When We Talk About Fat
2014 Standout
Tumor-associated macrophages: Effectors of angiogenesis and tumor progression
2009
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
1998 StandoutNature
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
2010
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
Neutrophils in cancer: neutral no more
2016 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Metastatic colonization by circulating tumour cells
2016 StandoutNature
The Theory of APL Revisited
2007
Transcription therapy for cancer
2001
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores
2008
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid Mice
2001
Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL
1998
A crucial role for Lyn in TIMP‐1 erythroid cell survival signalling pathway
2013 StandoutNobel
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Histone Acetylation Modifiers in the Pathogenesis of Malignant Disease
2000
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia
2001 Standout
Constitutive Expression of the Promyelocytic Leukemia–Associated Oncogene PML-RARα in TF1 Cells: Isoform-Specific and Retinoic Acid–Dependent Effects on Growth, bcl-2 Expression, and Apoptosis
1998
C/EBPα and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor γ Agonists
2009
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Transcription Factors, Normal Myeloid Development, and Leukemia
1997
Chromatin Remodeling and Leukemia: New Therapeutic Paradigms
1999
Emerging Roles for the Transforming Growth Factor-β Superfamily in Regulating Adiposity and Energy Expenditure
2010
CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development
2017
Three-dimensional organization of promyelocytic leukemia nuclear bodies
2010 StandoutNobel
Reduced Retinoic Acid-Sensitivities of Nuclear Receptor Corepressor Binding to PML- and PLZF-RARα Underlie Molecular Pathogenesis and Treatment of Acute Promyelocytic Leukemia
1998
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Histone Acetyltransferases
2001 Standout
Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B Study
1997
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Vesiculated Long Non-Coding RNAs: Offshore Packages Deciphering Trans-Regulation between Cells, Cancer Progression and Resistance to Therapies
2017
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
2014
Transcriptional regulation in acute promyelocytic leukemia
2001
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
1997
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
2000
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
2015
Interferon augments PML and PML/RAR alpha expression in normal myeloid and acute promyelocytic cells and cooperates with all-trans retinoic acid to induce maturation of a retinoid-resistant promyelocytic cell line
1996
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
2000 StandoutScience
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
2001
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
1999
Transcription Factors, Normal Myeloid Development, and Leukemia
1997
Works of Yu Wu being referenced
Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor Expression
2008
Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion
2010
Exome sequencing of a pedigree with tourette syndrome or chronic tic disorder
2011
Wdnm1-like, a new adipokine with a role in MMP-2 activation
2008
Characterization of ScAP-23, a new cell line from murine subcutaneous adipose tissue, identifies genes for the molecular definition of preadipocytes
2007
Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
2016
Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)
1995
CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process
2008